Mark Ragosa, CFO of Kiniksa Pharmaceuticals International KNSA, has filed 0 purchases and 24 sales on the open market. Over the past 12 months that comes to a net sale of $5.6M. The latest trade was on 04/07.

MR

MR

Mark Ragosa

CFO

Company

Kiniksa Pharmaceuticals International KNSA

First filing

23/03/20

Trades

170 trades

Buys / sales

0 / 24

12-month net buying

−$5.6M

Last trade

04/07

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	03/09	03/11	36,722 sh2 trades	$45.92avg.	$1,686,157.82	−75.2%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	02/09	02/11	17,845 sh2 trades	$43.28avg.	$772,254.22	−59.6%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	01/08	01/09	12,000 sh	$41.89	$502,680	−38.6%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	25/12/08	25/12/10	42,841 sh	$41.49	$1,777,473.09	−58.0%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	25/11/12	25/11/14	19,900 sh	$40.94	$814,706	−39.0%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	25/10/28	25/10/30	100 sh	$41.00	$4,100	−0.3%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	25/08/04	25/08/06	18,889 sh	$32.89	$621,259.21	−41.2%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	25/06/03	25/06/05	18,299 sh	$28.80	$527,011.2	−40.4%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	25/04/29–25/05/01	25/05/01	88,395 sh3 trades	$26.56avg.	$2,347,335.1	−76.6%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	25/03/20	25/03/24	15,944 sh	$23.11	$368,465.84	−40.5%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	25/03/17–25/03/19	25/03/19	20,343 sh2 trades	$23.10avg.	$469,923.3	−46.5%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	25/03/12	25/03/14	36,372 sh	$22.25	$809,277	−61.3%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	24/12/06–24/12/09	24/12/10	27,829 sh2 trades	$21.34avg.	$593,997.43	−54.8%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	24/12/03–24/12/05	24/12/05	15,116 sh3 trades	$21.37avg.	$323,008.8	−39.7%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	24/07/23	24/07/25	24,248 sh	$24.79	$601,107.92	−55.7%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	24/01/03	24/01/04	12,000 sh	$20.00	$240,000	−43.4%